SS Innovations International (SSII) Free Cash Flow Growth (1y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -1.82% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 226.77% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 9.73% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -51.69% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -109.40% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 133.09% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 363.84% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 108.16% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 29.12% |
| 10 | SS Innovations International | 770.31 Mn | 746.70 Mn | 5.33 Mn | 66.08% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 66.08% |
| Dec 31, 2025 | 4.51% |
| Sep 30, 2025 | -874.29% |
| Jun 30, 2025 | -20.24% |
| Mar 31, 2025 | -149.22% |
| Dec 31, 2024 | 25.08% |
| Sep 30, 2024 | 85.48% |
| Jun 30, 2024 | -7.14% |
| Mar 31, 2024 | -9.49% |
| Dec 31, 2023 | -59.27% |
| Sep 30, 2023 | -194.14% |
| Jun 30, 2023 | -160.95% |
| Mar 31, 2023 | -4,240.21% |
| Dec 31, 2022 | -2,376.53% |
| Sep 30, 2022 | -1,614.15% |
| Jun 30, 2022 | -1,966.56% |
| Mar 31, 2022 | 25.34% |
| Dec 31, 2021 | -1,835.82% |
| Sep 30, 2021 | -758.24% |
| Jun 30, 2021 | -160.38% |
| Mar 31, 2021 | -45.15% |
| Dec 31, 2020 | 93.77% |
| Sep 30, 2020 | 91.55% |
| Jun 30, 2020 | 44.34% |
| Mar 31, 2020 | 49.53% |
| Dec 31, 2019 | -0.54% |
| Sep 30, 2019 | -42.59% |
| Jun 30, 2019 | 69.56% |
| Mar 31, 2019 | 12.80% |
| Dec 31, 2018 | 36.80% |
| Sep 30, 2018 | -59.81% |
| Jun 30, 2018 | -2.87% |
| Mar 31, 2018 | -10.03% |
| Dec 31, 2017 | -153.51% |
| Sep 30, 2017 | 29.85% |